A detailed history of Mc Clarren Financial Advisors, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Mc Clarren Financial Advisors, Inc. holds 406 shares of VTRS stock, worth $5,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares
406
Previous 53 666.04%
Holding current value
$5,083
Previous $4,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$10.32 - $12.13 $3,642 - $4,281
353 Added 666.04%
406 $1,000
Q2 2024

Jul 26, 2024

SELL
$10.05 - $12.02 $4,009 - $4,795
-399 Reduced 88.27%
53 $4,000
Q1 2024

Jul 26, 2024

BUY
$11.27 - $13.53 $4,282 - $5,141
380 Added 527.78%
452 $6,000
Q1 2024

May 03, 2024

SELL
$11.27 - $13.53 $4,226 - $5,073
-375 Reduced 83.89%
72 $6,000
Q4 2023

Feb 02, 2024

BUY
$8.77 - $10.85 $61 - $75
7 Added 1.59%
447 $5,000
Q3 2023

Nov 03, 2023

SELL
$9.59 - $11.35 $911 - $1,078
-95 Reduced 17.76%
440 $4,000
Q2 2023

Aug 04, 2023

BUY
$9.02 - $10.29 $81 - $92
9 Added 1.71%
535 $5,000
Q1 2023

May 05, 2023

BUY
$9.2 - $12.26 $36 - $49
4 Added 0.77%
526 $2,000
Q4 2022

Jan 30, 2023

BUY
$8.72 - $11.56 $436 - $578
50 Added 10.59%
522 $5,000
Q3 2022

Oct 31, 2022

BUY
$8.48 - $11.13 $4,002 - $5,253
472 New
472 $4,000
Q2 2022

Aug 11, 2022

SELL
$9.95 - $12.27 $5,850 - $7,214
-588 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$9.81 - $15.4 $19 - $30
2 Added 0.34%
588 $6,000
Q4 2021

Jan 19, 2022

BUY
$12.09 - $14.68 $108 - $132
9 Added 1.56%
586 $8,000
Q3 2021

Oct 15, 2021

BUY
$13.25 - $15.13 $66 - $75
5 Added 0.87%
577 $7,000
Q2 2021

Jul 23, 2021

BUY
$12.97 - $16.15 $38 - $48
3 Added 0.53%
572 $7,000
Q4 2020

Jan 29, 2021

BUY
$14.3 - $18.74 $8,136 - $10,663
569 New
569 $10,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Mc Clarren Financial Advisors, Inc. Portfolio

Follow Mc Clarren Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Clarren Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Clarren Financial Advisors, Inc. with notifications on news.